Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendan Moran

Showing results (61-70 of 126) with videos related to

Pageof 13
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 16, 2022
Early postoperative intraperitoneal chemotherapy (EPIC) following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in 632 patients with pseudomyxoma peritonei of appendiceal origin: A single institution experienceXavier Fung, I Chuan Li, Kandiah Chandrakumaran, et al.
Minerva Chirurgica|July 5, 2019
A nationwide study on the adoption and short-term outcomes of transanal total mesorectal excision in the UKSapho X Roodbeen, Marta Penna, Steve Arnold, et al.
Journal of Clinical Pathology|June 22, 2012
Pathology and prognosis in pseudomyxoma peritonei: a review of 274 casesNorman J Carr, Jenny Finch, Ian Charles Ilesley, et al.
Annals of Surgical Oncology|July 15, 2024
The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Pseudomyxoma PeritoneiShigeki Kusamura, Jean-Baptiste Delhorme, Abdelkader Taibi, et al.
Techniques in Coloproctology|February 20, 2024
Evaluating geographical disparities on clinical outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapyAdrian Siu, Daniel Steffens, Nabila Ansari, et al.
Annals of Surgical Oncology|November 3, 2021
Overall Survival is More Closely Associated with Peritoneal than Primary Appendiceal Pathological Grade in Pseudomyxoma Peritonei with Discordant PathologyAyaz Ahmed Memon, Chintamani Godbole, Tom Cecil, et al.
European Journal of Clinical Nutrition|November 22, 2020
Outcomes of home parenteral nutrition in 34 patients with intestinal failure from recurrent or progressive peritoneal malignancy of gastro-intestinal tract originDavid Swain, Gemma Mason, Allison Yates, et al.
Pleura and Peritoneum|June 12, 2023
Correlation between PSOGI pathological classification and survival outcomes of patients with pseudomyxoma peritonei treated using cytoreductive surgery and HIPEC: national referral centre experience and literature reviewLorena Martín-Román, Enda Hannan, Mohammad Faraz Khan, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 15, 2024
Evaluating analgesia strategies in patients who have undergone oesophagectomy-a systematic review and network meta-analysis of randomised clinical trialsSinead Ramjit, Matthew G Davey, Caitlyn Loo, et al.
Annals of Surgery|April 28, 2015
Is the Combination of Distal Pancreatectomy and Cytoreductive Surgery With HIPEC Reasonable?: Results of an International Multicenter StudyLilian Schwarz, Konstantinos Votanopoulos, David Morris, et al.
Pageof 13

Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 16, 2022
Early postoperative intraperitoneal chemotherapy (EPIC) following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in 632 patients with pseudomyxoma peritonei of appendiceal origin: A single institution experienceXavier Fung, I Chuan Li, Kandiah Chandrakumaran, et al.
Minerva Chirurgica|July 5, 2019
A nationwide study on the adoption and short-term outcomes of transanal total mesorectal excision in the UKSapho X Roodbeen, Marta Penna, Steve Arnold, et al.
Journal of Clinical Pathology|June 22, 2012
Pathology and prognosis in pseudomyxoma peritonei: a review of 274 casesNorman J Carr, Jenny Finch, Ian Charles Ilesley, et al.
Annals of Surgical Oncology|July 15, 2024
The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Pseudomyxoma PeritoneiShigeki Kusamura, Jean-Baptiste Delhorme, Abdelkader Taibi, et al.
Techniques in Coloproctology|February 20, 2024
Evaluating geographical disparities on clinical outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapyAdrian Siu, Daniel Steffens, Nabila Ansari, et al.
Annals of Surgical Oncology|November 3, 2021
Overall Survival is More Closely Associated with Peritoneal than Primary Appendiceal Pathological Grade in Pseudomyxoma Peritonei with Discordant PathologyAyaz Ahmed Memon, Chintamani Godbole, Tom Cecil, et al.
European Journal of Clinical Nutrition|November 22, 2020
Outcomes of home parenteral nutrition in 34 patients with intestinal failure from recurrent or progressive peritoneal malignancy of gastro-intestinal tract originDavid Swain, Gemma Mason, Allison Yates, et al.
Pleura and Peritoneum|June 12, 2023
Correlation between PSOGI pathological classification and survival outcomes of patients with pseudomyxoma peritonei treated using cytoreductive surgery and HIPEC: national referral centre experience and literature reviewLorena Martín-Román, Enda Hannan, Mohammad Faraz Khan, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 15, 2024
Evaluating analgesia strategies in patients who have undergone oesophagectomy-a systematic review and network meta-analysis of randomised clinical trialsSinead Ramjit, Matthew G Davey, Caitlyn Loo, et al.
Annals of Surgery|April 28, 2015
Is the Combination of Distal Pancreatectomy and Cytoreductive Surgery With HIPEC Reasonable?: Results of an International Multicenter StudyLilian Schwarz, Konstantinos Votanopoulos, David Morris, et al.
Pageof 13